Please find all related articles below.
eHealth, mobile apps and digital medical services are sparking many hopes and concerns at the same time. The #Datacare debate held on 15 September 2015 at the European Parliament specifically explored the question, “What can data driven healthcare do for Europe?”
In our globalised, digital world, things are changing rapidly and technology is an inevitable, driving feature of innovation. In the future, health systems are likely to be permeated more and more by technology. Now is (...)
Public health is not just about human diseases, healthcare services or cross-border pandemics. Most of all, health is about people. Giving wider attention to the individual also fits perfectly with the European 2020 vision of ’smart, inclusive and sustainable’ growth for a healthier EU, as highlighted at a recent meeting on ’health literacy in Europe’ organised by STOA - European Parliament Science and Technology Options Assessment - on 1 July 2015.
People are used (...)
Unsurprisingly, mHealth was a hotly debated topic during the 2015 eHealth Week hosted by the Latvian Council Presidency. In addition to the official conference programme, where the mHealth summit uncovered some of the latest developments in this area, the European Commission also organised a stakeholder meeting including industry and civil society representatives to determine the appropriate level of regulation for mHealth at EU level.
European Health Commissioner Vytenis Andriukaitis (...)
Brussels, 11 May 2015 – The 2015 eHealth forum, organised under the auspices of the Latvian Presidency, will discuss the next steps regarding the further roll-out of eHealth in Europe. Mobile smartphone applications in particular have propelled eHealth to centre stage in recent years. As noted in the European Commission’s Green Paper on mobile Health (mHealth) (1), 100,000 health apps are already on the market and it is estimated that 50% of smartphone owners will be using them (...)
A new European Data in Health Research Alliance was launched in early December. This campaign, supported by a number of health organisations active across Europe and representing research, patient and public health concerns, was set up to demonstrate in the most tangible way that personal data in research is vital because it saves lives.
The Alliance was established by Cancer Research UK, the Medical Sciences Committee of Science Europe, European Patients’ Forum, the Federation of (...)
November 20014 - Despite the existence of various pro-public health guidelines, Mr. Juncker’s Commission Programme gives cause for concern.
The European Commission President Mr. Juncker and First Vice-President Mr. Timmermans outlined the draft list of key initiatives that constitute the Commission Work Programme (CWP), with an aim for it to be adopted in Strasbourg on December 16 after a discussion with the Members of the European Parliament. In a meantime, a number of political (...)
28 October 2014, Brussels – MEPs, patients and the European public health community are today asking President-elect Juncker to clarify whether medical devices and health technologies will remain in the directorate for health or not. Fears over patient safety remain as Mr Juncker has so far failed to publicly clarify his ambiguous statement (1) last week to the European Parliament.
Last week’s statement of the European Commission’s President-elect that the competence for (...)
Further to our Joint Letter of 16 September 2014 (1) , we are contacting you again to express our gratitude for your decision (2) to move the competence for medicines and pharmaceutical products back into the hands of the European Commissioner for Health. We firmly believe that this directorate is best placed to ensure a good balance between economic and public health objectives while promoting ‘smart, sustainable and inclusive’ growth for Europe.
28 October 2014, Brussels (...)
More integrated prevention and care models have long been recognised as important elements in moving towards better quality and sustainability in healthcare, in particular in view of the rising burden of non-communicable diseases and demographic change, and the complexities of multiple morbidities that this brings.
By Sascha Marschang, EPHA Policy Manager for Health Systems and Milena Richter, Senior Director European Public Affairs, Sanofi.
While healthcare systems move towards (...)
22 July 2014 - Following in-depth discussions with members, EPHA responded to the European Commission’s public consultation on its Green Paper on mobile health (mHealth) in early July. In its response, EPHA emphasises that mHealth development should not only be seen as a way to gain cost efficiencies, but that relevant solutions - including smartphone applications - must first and foremost aim to bring concrete benefits for different types of end users including patients and health (...)
Ageing and Older People
Health Rights and Patients